The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on May 22, 2026

From future of AI to geopolitics: WMF presents the training program with +90 stages and 1.000 international speakers
Cancer Vaccines Market to Witness Massive Growth by 2033 | NeoVax Bio, CelluVax Inc.
CEO of Leading Quantum Hardware Company Alice & Bob Responds to President Macron’s Strengthened Plan Quantique
Keolis MHI Celebrates International Day of Families with Special 'Work-Family Balance' Wellbeing Webinar
Breakfirst Games Releases Demo for Chaotic Couch Co-op Game Sheep & Socks
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis
Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Le compositeur espagnol Jordi Forniés présente Raíz y Recuerdo, Mémoire des racines
XS.com renforce sa présence en Amérique latine avec un nouveau sponsoring mondial au Wealth Expo Colombie
Alice & Bob announces Series B Extension
Transgene’s Combined General Meeting of May 22, 2026
Assemblée Générale Mixte de Transgene du 22 mai 2026
EXEL Industries: Half-year 2025–2026 results
EXEL Industries : Résultats semestriels 2025–2026
OSE Immunotherapeutics annonce les résultats de Topline positifs de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire en rechute
OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer
Bull liefert Finnlands neuen nationalen Supercomputer „Roihu“
Bull delivers Roihu, Finland’s new national supercomputer

Share this page:

Sign up for:

The France Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.